{
    "2020-12-04": [
        [
            {
                "time": "2021-01-05",
                "original_text": "Coronavirus update: Fauci to become Biden's chief medical adviser; United Health Group to study Eli Lilly antibody",
                "features": {
                    "keywords": [
                        "Fauci",
                        "Biden",
                        "United Health Group",
                        "Eli Lilly",
                        "antibody"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-01-06",
                "original_text": "Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare",
                "features": {
                    "keywords": [
                        "Humana",
                        "iCare",
                        "Medicare"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "Eli Lilly Rises on New Trial to Treat Covid in High-Risk Patients",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Covid",
                        "High-Risk",
                        "Trial"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-08",
                "original_text": "Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19",
                "features": {
                    "keywords": [
                        "Lilly",
                        "UnitedHealth Group",
                        "neutralizing antibody",
                        "bamlanivimab",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-09",
                "original_text": "Lilly and UnitedHealth launch trial of COVID-19 antibody",
                "features": {
                    "keywords": [
                        "Lilly",
                        "UnitedHealth",
                        "trial",
                        "COVID-19",
                        "antibody"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}